PRR12 Inhibitors
Chemical inhibitors of PRR12 can influence the protein's function through various modes of action by targeting different signaling pathways and cellular processes. Blebbistatin, a myosin II inhibitor, can impede the cellular mechanics and the cytoskeletal reorganization that are essential for the structural integrity of the nucleus where PRR12 operates. Similarly, Y-27632, a specific inhibitor of ROCK, can disrupt the actin cytoskeleton, potentially affecting the chromatin organization and spatial dynamics within the nucleus, which are critical for PRR12's role. PD 98059 and U0126, both inhibitors of MEK1/2, can interfere with the MAPK/ERK signaling pathway, which is implicated in gene expression regulation, a process where PRR12 is thought to be involved. SB 203580's inhibition of p38 MAP kinase, and SP600125's inhibition of JNK, can alter stress responses, apoptosis, and cell differentiation, processes that can require PRR12's regulatory functions.
Furthermore, LY294002 and Wortmannin, as PI3K inhibitors, can affect PRR12 by altering growth and survival signaling pathways, which are crucial for proper gene expression where PRR12 might play a regulatory role. Gö6976's inhibition of PKC can disrupt signaling pathways that regulate gene expression and the cell cycle, potentially influencing PRR12's function. Rapamycin's inhibition of mTOR can lead to changes in the gene expression patterns that involve PRR12. Dorsomorphin inhibits BMP signaling, which can affect cellular differentiation and gene expression, thereby influencing the regulatory roles of PRR12. Lastly, Thapsigargin, by inhibiting the SERCA pump and altering calcium signaling, can influence transcriptional processes and thus affect the function of PRR12 within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin inhibits myosin II, which is crucial for cytoskeletal reorganization and cell motility. Inhibition of myosin II can lead to altered cellular mechanics and indirectly inhibit PRR12 by disrupting its potential role in chromatin organization and nuclear structure, as PRR12 is linked to the regulation of these cellular components. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK (Rho-associated protein kinase), which plays a significant role in actin cytoskeleton organization. PRR12 is associated with chromosomal architecture, and its inhibition could be achieved through perturbation of cytoskeletal dynamics, affecting the spatial organization within the nucleus where PRR12 operates. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 selectively inhibits MEK1/2, upstream kinases in the MAPK/ERK pathway. PRR12 has been implicated in gene expression processes, which can be influenced by the MAPK/ERK signaling pathway. Inhibition of this pathway can alter the transcription machinery, potentially inhibiting PRR12 function in gene regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a selective inhibitor of p38 MAP kinase, involved in stress responses and cell differentiation. PRR12, given its role in gene expression, could be functionally inhibited by disrupting the cellular responses to stress and differentiation signals that may require PRR12's regulatory functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which is involved in various cellular processes, including apoptosis and cell differentiation. PRR12's function could be inhibited by interfering with JNK-mediated cellular processes that could involve PRR12's regulatory roles, particularly if PRR12 is implicated in gene expression linked to these processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which regulates numerous cellular functions, including growth and survival. PRR12's involvement in gene regulation could be indirectly inhibited by altering the cellular growth conditions and survival signaling pathways, which may require PRR12 function for proper gene expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor with a similar function to LY294002, potentially inhibiting PRR12 by affecting growth and survival pathways that may involve PRR12's regulatory role in the expression of genes necessary for these pathways. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is a selective inhibitor of protein kinase C (PKC), which is involved in various signaling pathways including those regulating gene expression and cell cycle. PRR12 may be functionally inhibited by disrupting PKC-mediated signaling pathways, which likely influence the regulatory role of PRR12 in gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is central to cell growth and metabolism. Inhibition of mTOR can lead to changes in gene expression patterns in which PRR12 might play a role. Therefore, by inhibiting mTOR, the function of PRR12 in gene regulation could be indirectly inhibited. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2 like PD 98059, and it serves a similar role in potentially inhibiting PRR12. By inhibiting MEK1/2, U0126 could indirectly inhibit PRR12 by affecting the ERK pathway, which could influence PRR12's role in gene expression regulation. | ||||||